T. Sellers

发表

to restraint stress in Sprague-Dawley rats corticosterone release and on HPA axis responsiveness Effect of voluntary wheel running on circadian

P. Snyder, T. Rosol, M. Riddell, 2015 .

Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice.

C. Davis, T. Hart, T. Sellers, 2001, The Journal of pharmacology and experimental therapeutics.

Flow Cytometry in the Preclinical Development of Biopharmaceuticals

D. Williams, Donna M. Williams, K. Gossett, 1999, Toxicologic pathology.

attenuated with long-term training sensitivity to adrenocorticotrophic hormone, which is Voluntary wheel running initially increases adrenal

P. Snyder, T. Rosol, M. Riddell, 2015 .

Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.

L. Schwartz, E. Minthorn, P. Bugelski, 2001, The Journal of allergy and clinical immunology.

Hemodynamic, hematologic and eicosanoid mediated mechanisms in 7.5 percent sodium chloride treatment of uncontrolled hemorrhagic shock.

T. Yue, G. Feuerstein, R. Rabinovici, 1992, Surgery, gynecology & obstetrics.

Attenuation of the inhibitory effect of prostacyclin on platelet function after tissue plasminogen activator or streptokinase infusion in the rabbit

E. Ohlstein, R. Shebuski, B. Storer, 1989 .

Interpreting Stress Responses during Routine Toxicity Studies

P. Snyder, T. Rosol, D. Creasy, 2013, Toxicologic pathology.

Cephalosporin‐induced immune cytopenia in the dog: Demonstration of erythrocyte‐, neutrophil‐, and platelet‐associated igg following treatment with cefazedone

A. Deldar, H. Lewis, P. Thiem, 1988, American journal of hematology.

Artifactual prolongation of the activated partial thromboplastin time associated with hemoconcentration in dogs.

S. O'Brien, T. Sellers, D. Meyer, 1995, Journal of veterinary internal medicine.

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist

J. Luengo, S. Miller, K. Duffy, 2009, Stem cells.

The hematopathology of cefonicid- and cefazedone-induced blood dyscrasias in the dog.

A. Deldar, H. Lewis, T. Sellers, 1987, Toxicology and applied pharmacology.

The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man.

A. Deldar, H. Lewis, T. Sellers, 1987, Toxicology and applied pharmacology.

Pharmacology and Safety of SB-497115-GR, an Orally Active Small Molecular Weight TPO Receptor Agonist, in Chimpanzees, Rats and Dogs.

T. Hart, T. Sellers, M. Semanik, 2004 .

The Effect of Human Recombinant Tissue-Type Plasminogen Activator on Clinical and Laboratory Parameters of Hemostasis and Systemic Plasminogen Activation in the Dog and the Rat

H. Lewis, T. Sellers, J. Bloom, 1988, Thrombosis and Haemostasis.

Altered hemostasis in male rats following administration of the ACAT inhibitor SKF-99085.

S. Rehm, K. Gossett, W. Kerns, 1998, Toxicological sciences : an official journal of the Society of Toxicology.

Eltrombopag: Investigation of Previously Reported Serum Discoloration and Negative Interference on a Total Bilirubin Diazo Method.

David F Adams, T. Sellers, 2016, Archives of pathology & laboratory medicine.

Technicon H*1® research software analysis of red cell changes in rats given an antineoplastic agent

K. Gossett, S. O'Brien, T. Sellers, 1996, Comparative Haematology International.

Expression and characterisation of finger protease (FP); a mutant tissue-type plasminogen activator (t-PA) with improved pharmacokinetics

J. Trill, K. Boyle, K. Johanson, 1990 .

Interspecies Pharmacokinetics of a Novel Hematoregulatory Peptide (SK&F 107647) in Rats, Dogs, and Oncologic Patients

David E. Martin, J. Nemunaitis, D. Brocks, 1996, Pharmaceutical Research.

Pharmacological profile of G619, a new platelet aggregation inhibitor.

T. Yue, G. Feuerstein, E. Ohlstein, 1992, Thrombosis research.